5/29
04:00 pm
mgx
Metagenomi to Present at the 2024 Jefferies Global Healthcare Conference
Low
Report
Metagenomi to Present at the 2024 Jefferies Global Healthcare Conference
5/15
12:25 pm
mgx
Metagenomi, Inc. (NASDAQ: MGX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Low
Report
Metagenomi, Inc. (NASDAQ: MGX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
5/14
04:16 pm
mgx
Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results [Yahoo! Finance]
Medium
Report
Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results [Yahoo! Finance]
5/14
04:05 pm
mgx
Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results
Medium
Report
Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results
5/7
07:18 am
mgx
Metagenomi, Inc. (NASDAQ: MGX) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $10.00 price target on the stock.
Low
Report
Metagenomi, Inc. (NASDAQ: MGX) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $10.00 price target on the stock.
5/2
07:06 am
mgx
Metagenomi, Inc. (NASDAQ: MGX) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. They now have a $6.00 price target on the stock, down previously from $16.00.
Medium
Report
Metagenomi, Inc. (NASDAQ: MGX) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. They now have a $6.00 price target on the stock, down previously from $16.00.
5/1
04:09 pm
mgx
Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems [Yahoo! Finance]
High
Report
Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems [Yahoo! Finance]
5/1
04:00 pm
mgx
Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems
High
Report
Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems
4/8
08:00 am
mgx
Metagenomi to Present at Upcoming Scientific Meetings
Medium
Report
Metagenomi to Present at Upcoming Scientific Meetings
3/28
08:24 am
mgx
Metagenomi, Inc. (NASDAQ: MGX) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $21.00 price target on the stock.
Medium
Report
Metagenomi, Inc. (NASDAQ: MGX) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $21.00 price target on the stock.
3/27
09:32 am
mgx
Metagenomi Reports Business Updates and Full Year 2023 Financial Results [Yahoo! Finance]
Low
Report
Metagenomi Reports Business Updates and Full Year 2023 Financial Results [Yahoo! Finance]
3/27
09:16 am
mgx
Metagenomi Reports Business Updates and Full Year 2023 Financial Results
Low
Report
Metagenomi Reports Business Updates and Full Year 2023 Financial Results
3/5
08:12 am
mgx
Metagenomi, Inc. (NASDAQ: MGX) is now covered by analysts at TD Cowen. They set an "outperform" rating on the stock.
Medium
Report
Metagenomi, Inc. (NASDAQ: MGX) is now covered by analysts at TD Cowen. They set an "outperform" rating on the stock.
3/5
07:43 am
mgx
Metagenomi, Inc. (NASDAQ: MGX) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $22.00 price target on the stock.
Medium
Report
Metagenomi, Inc. (NASDAQ: MGX) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $22.00 price target on the stock.
3/5
07:43 am
mgx
Metagenomi, Inc. (NASDAQ: MGX) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $16.00 price target on the stock.
Medium
Report
Metagenomi, Inc. (NASDAQ: MGX) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $16.00 price target on the stock.
3/5
07:43 am
mgx
Metagenomi, Inc. (NASDAQ: MGX) is now covered by analysts at Chardan Capital. They set a "buy" rating and a $21.00 price target on the stock.
Medium
Report
Metagenomi, Inc. (NASDAQ: MGX) is now covered by analysts at Chardan Capital. They set a "buy" rating and a $21.00 price target on the stock.
3/5
07:43 am
mgx
Metagenomi, Inc. (NASDAQ: MGX) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $23.00 price target on the stock.
Medium
Report
Metagenomi, Inc. (NASDAQ: MGX) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $23.00 price target on the stock.
3/5
07:43 am
mgx
Metagenomi, Inc. (NASDAQ: MGX) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $25.00 price target on the stock.
Medium
Report
Metagenomi, Inc. (NASDAQ: MGX) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $25.00 price target on the stock.